Icecure Medical Ltd (NASDAQ:ICCM)’s traded shares stood at 0.58 million during the last session, with the company’s beta value hitting 1.40. At the close of trading, the stock’s price was $1.05, to imply an increase of 4.46% or $0.04 in intraday trading. The ICCM share’s 52-week high remains $1.66, putting it -58.1% down since that peak but still an impressive 54.29% since price per share fell to its 52-week low of $0.48. The company has a valuation of $59.68M, with an average of 0.4 million shares in intraday trading volume over the past 10 days and average of 244.84K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Icecure Medical Ltd (ICCM), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ICCM a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Icecure Medical Ltd (NASDAQ:ICCM) trade information
After registering a 4.46% upside in the last session, Icecure Medical Ltd (ICCM) has traded red over the past five days. The 5-day price performance for the stock is 3.94%, and 3.43% over 30 days. With these gigs, the year-to-date price performance is 43.54%. Short interest in Icecure Medical Ltd (NASDAQ:ICCM) saw shorts transact 0.21 million shares and set a 0.93 days time to cover.
The extremes give us $2.5 and $5.75 for target low and target high price respectively. As such, ICCM has been trading -447.62% off suggested target high and -138.1% from its likely low.
ICCM Dividends
Icecure Medical Ltd has its next earnings report out on 2025-May-28. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Icecure Medical Ltd (NASDAQ:ICCM)’s Major holders
Icecure Medical Ltd insiders hold 47.55% of total outstanding shares, with institutional holders owning 0.22% of the shares at 0.42% float percentage. In total, 0.22% institutions holds shares in the company, led by CITADEL ADVISORS LLC. As of 2024-06-30, the company held over 0.17 million shares (or 0.3627% of shares), all amounting to roughly $0.13 million.
The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 66400.0 shares, or about 0.1421% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $49136.0.
